SALIX PHARMACEUTICALS LTD Operating Income
SALIX PHARMACEUTICALS LTD reported Operating Income of -$490.10 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD operating income (loss) for the quarter ending 2014-12-31 was -$423.44M, a 652.93% decline year-over-year.
- SALIX PHARMACEUTICALS LTD operating income (loss) for the quarter ending 2014-09-30 was -$79.63M, a 204.34% decline year-over-year.
- SALIX PHARMACEUTICALS LTD operating income (loss) for the quarter ending 2014-06-30 was $42.98M, a 14.29% decline year-over-year.
- SALIX PHARMACEUTICALS LTD operating income (loss) for the quarter ending 2014-03-31 was -$20.22M, a 141.03% decline year-over-year.
- SALIX PHARMACEUTICALS LTD operating income (loss) for fiscal 2014 was -$490.10M, a 294.24% decline from fiscal 2013.
- SALIX PHARMACEUTICALS LTD operating income (loss) for fiscal 2013 was $252.31M, a 46.63% increase from fiscal 2012.
- SALIX PHARMACEUTICALS LTD operating income (loss) for fiscal 2012 was $172.07M, a 48.50% increase from fiscal 2011.
- SALIX PHARMACEUTICALS LTD operating income (loss) for fiscal 2011 was $115.87M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | -$423.44M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | -$512.86M derived: sum of 2 quarters · filed 2015-03-02 | -$469.88M derived: sum of 3 quarters · filed 2015-03-02 | -$490.10M 10-K · filed 2015-03-02 | ||||
| 2014-09-30 | -$79.63M 10-Q · filed 2014-11-07 | -$46.44M derived: sum of 2 quarters · filed 2015-03-02 | -$66.66M 10-Q/A · filed 2015-03-02 | -$69.27M 10-Q · filed 2014-11-07 | $9.93M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2014-06-30 | $42.98M 10-Q/A · filed 2015-03-02 | $48.45M 10-Q · filed 2014-08-08 | $22.76M 10-Q/A · filed 2015-03-02 | $10.36M 10-Q · filed 2014-08-08 | $99.34M derived: sum of 3 quarters · filed 2015-03-02 | $175.65M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2014-03-31 | -$20.22M 10-Q/A · filed 2015-03-02 | -$38.09M 10-Q · filed 2014-05-09 | $56.36M derived: sum of 2 quarters · filed 2015-03-02 | $132.68M derived: sum of 3 quarters · filed 2015-03-02 | $182.82M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-12-31 | $76.58M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $152.90M derived: sum of 2 quarters · filed 2015-03-02 | $203.04M derived: sum of 3 quarters · filed 2015-03-02 | $252.31M 10-K · filed 2015-03-02 | $271.71M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $76.31M 10-Q/A · filed 2015-03-02 | $126.46M derived: sum of 2 quarters · filed 2015-03-02 | $175.73M 10-Q/A · filed 2015-03-02 | $222.63M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $50.14M 10-Q/A · filed 2015-03-02 | $99.42M 10-Q/A · filed 2015-03-02 | $146.31M derived: sum of 3 quarters · filed 2015-03-02 | $189.07M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $49.27M 10-Q/A · filed 2015-03-02 | $96.17M derived: sum of 2 quarters · filed 2015-03-02 | $138.93M derived: sum of 3 quarters · filed 2015-03-02 | $182.89M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $46.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $89.65M derived: sum of 2 quarters · filed 2015-03-02 | $133.62M derived: sum of 3 quarters · filed 2015-03-02 | $172.07M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $42.75M 10-Q · filed 2013-11-08 | $86.72M derived: sum of 2 quarters · filed 2013-11-08 | $125.17M 10-Q · filed 2013-11-08 | $149.72M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-06-30 | $43.97M 10-Q · filed 2013-08-09 | $82.42M 10-Q · filed 2013-08-09 | $106.97M derived: sum of 3 quarters · filed 2015-03-02 | $160.02M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-03-31 | $38.45M 10-Q · filed 2013-05-10 | $63.00M derived: sum of 2 quarters · filed 2015-03-02 | $116.05M derived: sum of 3 quarters · filed 2015-03-02 | $146.94M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2011-12-31 | $24.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $77.60M derived: sum of 2 quarters · filed 2015-03-02 | $108.49M derived: sum of 3 quarters · filed 2015-03-02 | $115.87M 10-K · filed 2015-03-02 | ||||
| 2011-09-30 | $53.05M 10-Q · filed 2012-11-08 | $83.94M derived: sum of 2 quarters · filed 2012-11-08 | $91.33M 10-Q · filed 2012-11-08 | $124.50M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $30.89M 10-Q · filed 2012-08-09 | $38.28M 10-Q · filed 2012-08-09 | $71.45M derived: sum of 3 quarters · filed 2013-03-01 | $75.94M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $7.38M 10-Q · filed 2012-05-08 | $40.55M derived: sum of 2 quarters · filed 2013-03-01 | $45.05M derived: sum of 3 quarters · filed 2013-03-01 | $25.02M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $33.17M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $37.67M derived: sum of 2 quarters · filed 2013-03-01 | $17.64M derived: sum of 3 quarters · filed 2013-03-01 | -$6.18M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $4.50M 10-Q · filed 2011-11-09 | -$15.53M derived: sum of 2 quarters · filed 2011-11-09 | -$39.35M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | -$20.03M 10-Q · filed 2011-08-09 | -$43.84M 10-Q · filed 2011-08-09 | ||||||
| 2010-03-31 | -$23.81M 10-Q · filed 2011-05-10 | |||||||
| 2009-12-31 | -$40.11M 10-K · filed 2012-02-28 |